Canada - English - Health Canada

apotex inc - trimipramine (trimipramine maleate) - tablet - 12.5mg - trimipramine (trimipramine maleate) 12.5mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

apotex inc - trimipramine (trimipramine maleate) - tablet - 25mg - trimipramine (trimipramine maleate) 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

apotex inc - trimipramine (trimipramine maleate) - tablet - 50mg - trimipramine (trimipramine maleate) 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

apotex inc - trimipramine (trimipramine maleate) - tablet - 100mg - trimipramine (trimipramine maleate) 100mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

apotex inc - trimipramine (trimipramine maleate) - capsule - 75mg - trimipramine (trimipramine maleate) 75mg - tricyclics and other norepinephrine-reuptake inhibitors

United States - English - NLM (National Library of Medicine)

breckenridge pharmaceutical, inc. - trimipramine maleate (unii: 269k6498ld) (trimipramine - unii:6s082c9ndt) - trimipramine 25 mg - trimipramine maleate capsules are indicated for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. in studies with neurotic outpatients, the drug appeared to be equivalent to amitriptyline in the less-depressed patients but somewhat less effective than amitriptyline in the more severely depressed patients. in hospitalized depressed patients, trimipramine and imipramine were equally effective in relieving depression. the use of maois intended to treat psychiatric disorders with trimipramine maleate capsules or within 14 days of stopping treatment with trimipramine maleate capsules is contraindicated because of an increased risk of serotonin syndrome. the use of trimipramine maleate capsules within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting trimipramine maleate capsules in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). cross-sensitivity between trimipramine maleate capsules and other dibenzazepines is a possibility. the drug is contraindicated during the acute recovery period after a myocardial infarction.

Canada - English - Health Canada

nu-pharm inc - trimipramine (trimipramine maleate) - tablet - 12.5mg - trimipramine (trimipramine maleate) 12.5mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

nu-pharm inc - trimipramine (trimipramine maleate) - tablet - 100mg - trimipramine (trimipramine maleate) 100mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

nu-pharm inc - trimipramine (trimipramine maleate) - tablet - 50mg - trimipramine (trimipramine maleate) 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

nu-pharm inc - trimipramine (trimipramine maleate) - tablet - 25mg - trimipramine (trimipramine maleate) 25mg - tricyclics and other norepinephrine-reuptake inhibitors